Intra-arterial delivery of mesenchymal stem cells
Authors:
Open Access
- 1 January 2016
- journal article
- review article
- Published by Medknow in Brain Circulation
- Vol. 2 (3) , 114-117
Abstract
While treatments have been developed to combat stroke, such as intravenous recombinant tissue plasminogen activator and endovascular recanalization therapies, their ability to decrease the long-term disability that accompanies stroke is limited. Currently, stem cell research focused on mesenchymal stem cells (MSCs). MSCs are multipotent, nonhematopoietic stem cells found in the stromal fraction of the bone marrow, along with the connective tissue of most organs. MSCs are an increasingly appealing cell source due to the relative ease in which they can be retrieved, developed, and handled in vitro. Despite the fact that numerous paths of stem cell transport to the brain in acute ischemic stroke (AIS) exist, the intra-arterial (IA) route of stem cell transport is most attractive. This is due to its great potential for clinical translation, especially considering the growing clinical application of endovascular treatment for AIS. Here, we evaluate research examining IA delivery of MSCs to the stroke region. The results of the study revealed the maximum tolerated dose and that the optimal time for administration was 24 h, following cerebral ischemia. It is important that future translational studies are performed to establish IA administration of MSCs as a widely used treatment for AIS.Keywords
This publication has 28 references indexed in Scilit:
- Executive Summary: Heart Disease and Stroke Statistics—2010 UpdateCirculation, 2010
- Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen ActivatorStroke, 2009
- S tem Cell T herapies as an E merging P aradigm in S troke (STEPS)Stroke, 2009
- Translating Interventions from Ischemic Stroke Models to Patients: The View in 20092009
- Cell Therapy for Age-Related Disorders: Myocardial Infarction and Stroke – A Mini-ReviewGerontology, 2008
- Dual-Modality Monitoring of Targeted Intraarterial Delivery of Mesenchymal Stem Cells After Transient IschemiaStroke, 2008
- Cell Transplantation Therapy for StrokeStroke, 2007
- Behavioral and Histological Evaluation of a Focal Cerebral Infarction Rat Model Transplanted With Neurons Induced from Bone Marrow Stromal CellsJournal of Neuropathology & Experimental Neurology, 2005
- Mesenchymal Stem Cells and Their Potential as Cardiac TherapeuticsCirculation Research, 2004
- Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in RatsStroke, 2001